Published in Ann Intern Med on September 01, 1994
Molecular diagnosis of herpes simplex virus infections in the central nervous system. J Clin Microbiol (1999) 2.21
Laboratory diagnosis of common viral infections of the central nervous system by using a single multiplex PCR screening assay. J Clin Microbiol (1999) 2.12
The role of laboratory investigation in the diagnosis and management of patients with suspected herpes simplex encephalitis: a consensus report. The EU Concerted Action on Virus Meningitis and Encephalitis. J Neurol Neurosurg Psychiatry (1996) 1.87
Aseptic meningitis and viral myelitis. Neurol Clin (2008) 1.49
Comparative evaluation of colorimetric microtiter plate systems for detection of herpes simplex virus in cerebrospinal fluid. J Clin Microbiol (1998) 1.49
Limits in reliability of glycoprotein G-based type-specific serologic assays for herpes simplex virus types 1 and 2. J Clin Microbiol (1999) 1.22
Difficult and recurrent meningitis. J Neurol Neurosurg Psychiatry (2004) 1.22
Herpes simplex virus latency-associated transcript sequence downstream of the promoter influences type-specific reactivation and viral neurotropism. J Virol (2007) 1.15
Increased detection rate in diagnosis of herpes simplex virus type 2 meningitis by real-time PCR using cerebrospinal fluid samples. J Clin Microbiol (2007) 0.91
Mollaret's meningitis caused by herpes simplex virus type 2: case report and literature review. Eur J Clin Microbiol Infect Dis (2004) 0.85
Increased cell-mediated immune responses in patients with recurrent herpes simplex virus type 2 meningitis. Clin Vaccine Immunol (2011) 0.84
Clinical validation of a new triplex real-time polymerase chain reaction assay for the detection and discrimination of Herpes simplex virus types 1 and 2. J Mol Diagn (2008) 0.82
Molecular techniques for clinical diagnostic virology. J Clin Pathol (2000) 0.77
Mollaret-like cells in patients with West Nile virus infection. Emerg Infect Dis (2004) 0.75
HIV-Associated CNS Vasculopathy in the Modern Era. J Clin Neurol (2016) 0.75
A 20-year-old woman with headache and transient numbness. Neurohospitalist (2013) 0.75
Recurrent Meningitis. Curr Pain Headache Rep (2017) 0.75
A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med (2005) 17.06
Immediate-early regulatory gene mutants define different stages in the establishment and reactivation of herpes simplex virus latency. J Virol (1989) 5.77
Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group. N Engl J Med (1993) 5.67
Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV Vaccine Study Group. JAMA (1999) 4.91
Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women. JAMA (2001) 4.54
Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. N Engl J Med (2000) 4.39
Risk factors for the sexual transmission of genital herpes. Ann Intern Med (1992) 3.89
Antibody protects against lethal infection with the neurally spreading reovirus type 3 (Dearing). J Virol (1988) 3.84
Recurrence rates in genital herpes after symptomatic first-episode infection. Ann Intern Med (1994) 3.83
A nondefective (competent) adenovirus-SV40 hybrid isolated from the AD.2-SV40 hybrid population. Proc Natl Acad Sci U S A (1969) 3.81
Antibody to herpes simplex virus type 2 as serological marker of sexual lifestyle in populations. BMJ (1994) 3.71
Growth inhibition by acycloguanosine of herpesviruses isolated from human infections. Antimicrob Agents Chemother (1979) 3.61
Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate. Proc Natl Acad Sci U S A (1989) 3.26
Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor. N Engl J Med (1991) 3.19
Studies of nondefective adenovirus 2-simian virus 40 hybrid viruses. V. Isolation of additional hybrids which differ in their simian virus 40-specific biological properties. J Virol (1973) 2.87
Creutzfeldt-Jakob disease and bovine spongiform encephalopathy: any connection? BMJ (1995) 2.74
An unusual infection due to staphylococcus aureus. N Engl J Med (1971) 2.68
Distinct pathways of viral spread in the host determined by reovirus S1 gene segment. Science (1986) 2.61
Chronic fatigue. A prospective clinical and virologic study. JAMA (1990) 2.54
HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy. Neurology (1999) 2.49
Resistance to antiviral drugs of herpes simplex virus isolated from a patient treated with acyclovir. N Engl J Med (1982) 2.37
Monoclonal antibodies to reovirus reveal structure/function relationships between capsid proteins and genetics of susceptibility to antibody action. J Virol (1991) 2.37
Atypical herpes simplex virus encephalitis diagnosed by PCR amplification of viral DNA from CSF. Neurology (1998) 2.26
Identification of attenuating mutations on the reovirus type 3 S1 double-stranded RNA segment with a rapid sequencing technique. J Virol (1986) 2.15
Rapid detection of respiratory syncytial virus in nasopharyngeal secretions by enzyme-linked immunosorbent assay. J Clin Microbiol (1985) 2.10
Frequent detection of genital herpes simplex virus DNA by polymerase chain reaction among pregnant women. JAMA (1994) 2.03
Development of clinically recognizable genital lesions among women previously identified as having "asymptomatic" herpes simplex virus type 2 infection. Ann Intern Med (1989) 2.03
Prevention of cytomegalovirus infection by cytomegalovirus immune globulin after marrow transplantation. Ann Intern Med (1983) 2.03
Studies of nondefective adenovirus 2-simian virus 40 hybrid viruses. VII. Characterization of the simian virus 40 RNA species induced by five nondefective hybrid viruses. J Virol (1973) 2.02
Human herpesvirus 6 in lung tissue from patients with pneumonitis after bone marrow transplantation. N Engl J Med (1993) 2.01
Virus-specific nucleic acids in SV40-exposed hamster embryo cell lines: correlation with S and T antigens. Proc Natl Acad Sci U S A (1969) 1.97
Molecular basis of viral neurotropism: experimental reovirus infection. Neurology (1985) 1.94
Reovirus infection and tissue injury in the mouse central nervous system are associated with apoptosis. J Virol (1997) 1.90
Use of subgenomic poliovirus DNA hybridization probes to detect the major subgroups of enteroviruses. J Clin Microbiol (1984) 1.90
Clinical course of patients with serologic evidence of recurrent genital herpes presenting with signs and symptoms of first episode disease. Sex Transm Dis (1999) 1.88
Detection of parasite DNA in Chagas' heart disease. Lancet (1995) 1.86
Reovirus-induced apoptosis of MDCK cells is not linked to viral yield and is blocked by Bcl-2. J Virol (1997) 1.84
Progressive esophagitis from acyclovir-resistant herpes simplex. Clinical roles for DNA polymerase mutants and viral heterogeneity? Ann Intern Med (1989) 1.78
Isotope selection for patients undergoing prostate brachytherapy. Int J Radiat Oncol Biol Phys (1999) 1.71
Humoral immune response to HSV-1 and HSV-2 viral proteins in patients with primary genital herpes. J Med Virol (1985) 1.71
Herpes simplex virus type 1 DNA in cerebrospinal fluid of a patient with Mollaret's meningitis. N Engl J Med (1991) 1.69
Reovirus-induced apoptosis requires activation of transcription factor NF-kappaB. J Virol (2000) 1.68
Neonatal enterovirus infection: virology, serology, and effects of intravenous immune globulin. Clin Infect Dis (1995) 1.66
Reovirus-induced apoptosis is mediated by TRAIL. J Virol (2000) 1.62
Specificity of the blastogenic response of human mononuclear cells to herpesvirus antigens. Infect Immun (1978) 1.60
Studies of nondefective adenovirus 2-simian virus 40 hybrid viruses. 3. Base composition, molecular weight, and conformation of the Ad2+ND genome. J Virol (1971) 1.59
Serotypes and electropherotypes of human rotavirus in the USA: 1987-1989. J Infect Dis (1990) 1.54
Seroprevalence of herpes simplex virus infections in a family medicine clinic. Arch Fam Med (1995) 1.52
Functional analysis of the intergenic regions of TcP2beta gene loci allowed the construction of an improved Trypanosoma cruzi expression vector. Gene (1999) 1.50
Comparison of the Western immunoblot assay and a glycoprotein G enzyme immunoassay for detection of serum antibodies to herpes simplex virus type 2 in patients with AIDS. J Clin Microbiol (1992) 1.49
Molecular karyotype of clone CL Brener chosen for the Trypanosoma cruzi genome project. Mol Biochem Parasitol (1995) 1.48
Factors affecting the detection of enteroviruses in cerebrospinal fluid with coxsackievirus B3 and poliovirus 1 cDNA probes. J Clin Microbiol (1985) 1.47
Immune response to herpesvirus antigens in adults with acute cytomegaloviral mononucleosis. J Infect Dis (1979) 1.46
Evaluation of recombinant antigens for serodiagnosis of Chagas' disease in South and Central America. J Clin Microbiol (1999) 1.45
Transmission of genital herpes in couples with one symptomatic and one asymptomatic partner: a prospective study. J Infect Dis (1988) 1.44
Interferon and transcription of early virus-specific RNA in cells infected with simian virus 40. Proc Natl Acad Sci U S A (1971) 1.43
Human herpesvirus 6 DNA in peripheral blood cells and saliva from immunocompetent individuals. J Clin Microbiol (1993) 1.42
Virus-specific deoxyribonucleic acid in simian virus 40-exposed hamster cells: correlation with S and T antigens. J Virol (1970) 1.42
PCR-based screening and lineage identification of Trypanosoma cruzi directly from faecal samples of triatomine bugs from northwestern Argentina. Parasitology (2006) 1.42
Interferon inhibits the in vitro accumulation of virus specific RNA in nuclei isolated from SV40 infected cells. Biochem Biophys Res Commun (1977) 1.41
Airborne transmission of chickenpox in a hospital. N Engl J Med (1980) 1.39
Nucleotide cDNA and complete deduced amino acid sequence of a Trypanosoma cruzi ribosomal P protein (P-JL5). Nucleic Acids Res (1990) 1.38
Genetic basis for altered pathogenesis of an immune-selected antigenic variant of reovirus type 3 (Dearing). J Virol (1986) 1.38
Relationship between antibodies to herpes simplex virus (HSV) and symptoms of HSV infection. J Infect Dis (1996) 1.36
Nonisotopic oligomeric probes for the human enteroviruses. J Clin Microbiol (1988) 1.36
Persistence of the efficacy of zoster vaccine in the shingles prevention study and the short-term persistence substudy. Clin Infect Dis (2012) 1.36
Inhibition of human herpesviruses by combination of acyclovir and human leukocyte interferon. Infect Immun (1981) 1.35
A randomized vehicle-controlled trial of topical capsaicin in the treatment of postherpetic neuralgia. Clin Ther (1993) 1.33
Lymphocytes protect against and are not required for reovirus-induced myocarditis. J Virol (1993) 1.33
Reovirus-induced G(2)/M cell cycle arrest requires sigma1s and occurs in the absence of apoptosis. J Virol (2000) 1.31
Reovirus-induced apoptosis is preceded by increased cellular calpain activity and is blocked by calpain inhibitors. J Virol (1999) 1.30
Reovirus-induced apoptosis requires both death receptor- and mitochondrial-mediated caspase-dependent pathways of cell death. Cell Death Differ (2002) 1.29
Cellular immunity to varicella-zoster virus in patients with major depression. J Infect Dis (1998) 1.27
Development and application of RNA probes for the study of picornaviruses. Mol Cell Probes (1988) 1.27
Transferrin gene expression visualized in oligodendrocytes of the rat brain by using in situ hybridization and immunohistochemistry. Proc Natl Acad Sci U S A (1985) 1.26
In vitro evaluations of condoms with and without nonoxynol 9 as physical and chemical barriers against Chlamydia trachomatis, herpes simplex virus type 2, and human immunodeficiency virus. Sex Transm Dis (1989) 1.25
Evaluation of varicella-zoster immune globulin: protection of immunosuppressed children after household exposure to varicella. J Infect Dis (1983) 1.24
Reovirus-induced apoptosis: A minireview. Apoptosis (2003) 1.24
Urinary morbidity following ultrasound-guided transperineal prostate seed implantation. Int J Radiat Oncol Biol Phys (1999) 1.23
Molecular mimicry between the immunodominant ribosomal protein P0 of Trypanosoma cruzi and a functional epitope on the human beta 1-adrenergic receptor. J Exp Med (1995) 1.23
Differential profile and biochemical effects of antiautonomic membrane receptor antibodies in ventricular arrhythmias and sinus node dysfunction. Circulation (2001) 1.23
Limits in reliability of glycoprotein G-based type-specific serologic assays for herpes simplex virus types 1 and 2. J Clin Microbiol (1999) 1.22
Chlamydia pneumoniae, herpes simplex virus type 1, and cytomegalovirus and incident myocardial infarction and coronary heart disease death in older adults : the Cardiovascular Health Study. Circulation (2000) 1.22
Immunization of high-risk infants younger than 18 months of age with split-product influenza vaccine. Pediatrics (1991) 1.21
Role of immune cells in protection against and control of reovirus infection in neonatal mice. J Virol (1991) 1.20
Examining the role of neoadjuvant androgen deprivation in patients undergoing prostate brachytherapy. J Clin Oncol (2000) 1.19
Antifungal activity of four tetracycline analogues against Candida albicans in vitro: potentiation by amphotericin B. J Infect Dis (1977) 1.18
Comparison of neutralization and DNA restriction enzyme methods for typing clinical isolates of human adenovirus. J Clin Microbiol (1985) 1.18
RNA target loss during solid phase hybridization of body fluids--a quantitative study. Mol Cell Probes (1987) 1.18
Comparison of diploid fibroblast and rabbit kidney tissue cultures and a diploid fibroblast microtiter plate system for the isolation of herpes simplex virus. J Clin Microbiol (1988) 1.18
Correlates of opportunistic infections in children infected with the human immunodeficiency virus managed before highly active antiretroviral therapy. Pediatr Infect Dis J (2001) 1.18
Reovirus infection activates JNK and the JNK-dependent transcription factor c-Jun. J Virol (2001) 1.18
Profile of enterovirus disease in the first two weeks of life. Pediatr Infect Dis J (1993) 1.17
The relationship of human papillomavirus-related cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex virus type 2 infection. Cancer Epidemiol Biomarkers Prev (1996) 1.17
Protective antibodies inhibit reovirus internalization and uncoating by intracellular proteases. J Virol (1994) 1.17
Calpain inhibition protects against virus-induced apoptotic myocardial injury. J Virol (2001) 1.17